Nutritional Supplements in Polycystic Ovary Syndrome: A State-of-the-Art Review
The Journal of Reproduction · 2025-12 · 3 (1) · 4-13
DOI: 10.58779/tjorvol3num1art1 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Reproduction, 2025-12. Verfasst von Héctor Iván Saldívar Cerón und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder affecting women of reproductive age, characterized by hyperandrogenism, oligo-ovulation, and polycystic ovarian morphology. Despite its high prevalence and significant impact on quality of life, the etiology of PCOS remains unclear. Current treatment strategies primarily focus on symptom management and include lifestyle modifications, such as diet and exercise, as well as pharmacological interventions. However, these approaches often have limited efficacy and may be associated with adverse effects. In recent years, there has been growing interest in the use of nutritional supplements as adjuvant therapies for PCOS. Myoinositol and D-chiro-inositol, two naturally occurring isomers of inositol, have emerged as promising candidates due to their roles in insulin signaling and ovarian function. Clinical studies have demonstrated that supplementation with inositol can improve menstrual regularity, reduce hyperandrogenism, and enhance ovulation in women with PCOS. Vitamin D deficiency is also common in women with PCOS and has been associated with insulin resistance and metabolic abnormalities. Supplementation with vitamin D has been shown to improve insulin sensitivity and menstrual regularity in this population. Omega-3 fatty acids, such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), have anti-inflammatory properties and may help alleviate symptoms of PCOS, including hyperandrogenism and insulin resistance. Curcumin, a natural polyphenol derived from the turmeric plant, has antioxidant and anti-inflammatory effects and has shown promise in improving insulin sensitivity and lipid profiles in women with PCOS. Despite the promising results from clinical studies, further research is needed to elucidate the mechanisms of action and optimal dosing of these supplements in PCOS. Additionally, long-term safety data are lacking, and more studies are needed to assess the potential risks and benefits of supplementation in this population. Overall, nutritional supplements represent a promising adjunctive therapy for PCOS, but further research is needed to establish their role in the management of this complex disorder.
Zitieren
APA
Cerón, H. I. S., & Millán, C. R. R. (2025). Nutritional Supplements in Polycystic Ovary Syndrome: A State-of-the-Art Review. The Journal of Reproduction, 3(1), 4-13. https://doi.org/10.58779/tjorvol3num1art1
Vancouver
Cerón HIS, Millán CRR. Nutritional Supplements in Polycystic Ovary Syndrome: A State-of-the-Art Review. The Journal of Reproduction. 2025;3(1):4-13. doi:10.58779/tjorvol3num1art1
BibTeX
@article{Cern2025,
author = {Cerón, Héctor Iván Saldívar and Millán, Carlos Raúl Robledo},
title = {Nutritional Supplements in Polycystic Ovary Syndrome: A State-of-the-Art Review},
journal = {The Journal of Reproduction},
year = {2025},
volume = {3},
number = {1},
pages = {4--13},
doi = {10.58779/tjorvol3num1art1}
}
EUVIMED